304 related articles for article (PubMed ID: 24704989)
1. Secondary neutron doses received by paediatric patients during intracranial proton therapy treatments.
Sayah R; Farah J; Donadille L; Hérault J; Delacroix S; De Marzi L; De Oliveira A; Vabre I; Stichelbaut F; Lee C; Bolch WE; Clairand I
J Radiol Prot; 2014 Jun; 34(2):279-96. PubMed ID: 24704989
[TBL] [Abstract][Full Text] [Related]
2. Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms.
Zacharatou Jarlskog C; Lee C; Bolch WE; Xu XG; Paganetti H
Phys Med Biol; 2008 Feb; 53(3):693-717. PubMed ID: 18199910
[TBL] [Abstract][Full Text] [Related]
3. Secondary Neutron Doses to Pediatric Patients During Intracranial Proton Therapy: Monte Carlo Simulation of the Neutron Energy Spectrum and its Organ Doses.
Matsumoto S; Koba Y; Kohno R; Lee C; Bolch WE; Kai M
Health Phys; 2016 Apr; 110(4):380-6. PubMed ID: 26910030
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo modeling of proton therapy installations: a global experimental method to validate secondary neutron dose calculations.
Farah J; Martinetti F; Sayah R; Lacoste V; Donadille L; Trompier F; Nauraye C; De Marzi L; Vabre I; Delacroix S; Hérault J; Clairand I
Phys Med Biol; 2014 Jun; 59(11):2747-65. PubMed ID: 24800943
[TBL] [Abstract][Full Text] [Related]
5. Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy.
Moteabbed M; Geyer A; Drenkhahn R; Bolch WE; Paganetti H
Phys Med Biol; 2012 Jan; 57(2):499-515. PubMed ID: 22217682
[TBL] [Abstract][Full Text] [Related]
6. Secondary neutron doses in proton therapy treatments of ocular melanoma and craniopharyngioma.
Farah J; Sayah R; Martinetti F; Donadille L; Lacoste V; Hérault J; Delacroix S; Nauraye C; Vabre I; Lee C; Bolch WE; Clairand I
Radiat Prot Dosimetry; 2014 Oct; 161(1-4):363-7. PubMed ID: 24222710
[TBL] [Abstract][Full Text] [Related]
7. Configuration and validation of an analytical model predicting secondary neutron radiation in proton therapy using Monte Carlo simulations and experimental measurements.
Farah J; Bonfrate A; De Marzi L; De Oliveira A; Delacroix S; Martinetti F; Trompier F; Clairand I
Phys Med; 2015 May; 31(3):248-56. PubMed ID: 25682475
[TBL] [Abstract][Full Text] [Related]
8. Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy.
Athar BS; Paganetti H
Phys Med Biol; 2009 Aug; 54(16):4907-26. PubMed ID: 19641238
[TBL] [Abstract][Full Text] [Related]
9. Neutron H*(10) inside a proton therapy facility: comparison between Monte Carlo simulations and WENDI-2 measurements.
De Smet V; Stichelbaut F; Vanaudenhove T; Mathot G; De Lentdecker G; Dubus A; Pauly N; Gerardy I
Radiat Prot Dosimetry; 2014 Oct; 161(1-4):417-21. PubMed ID: 24255173
[TBL] [Abstract][Full Text] [Related]
10. Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton Therapy.
De Saint-Hubert M; Verbeek N; Bäumer C; Esser J; Wulff J; Nabha R; Van Hoey O; Dabin J; Stuckmann F; Vasi F; Radonic S; Boissonnat G; Schneider U; Rodriguez M; Timmermann B; Thierry-Chef I; Brualla L
Front Oncol; 2022; 12():882489. PubMed ID: 35756661
[TBL] [Abstract][Full Text] [Related]
11. Impact of irradiation setup in proton spot scanning brain therapy on organ doses from secondary radiation.
Ardenfors O; Gudowska I; Flejmer AM; Dasu A
Radiat Prot Dosimetry; 2018 Aug; 180(1-4):261-266. PubMed ID: 30085315
[TBL] [Abstract][Full Text] [Related]
12. Shielding implications for secondary neutrons and photons produced within the patient during IMPT.
DeMarco J; Kupelian P; Santhanam A; Low D
Med Phys; 2013 Jul; 40(7):071701. PubMed ID: 23822405
[TBL] [Abstract][Full Text] [Related]
13. Measurement of stray radiation within a scanning proton therapy facility: EURADOS WG9 intercomparison exercise of active dosimetry systems.
Farah J; Mares V; Romero-Expósito M; Trinkl S; Domingo C; Dufek V; Klodowska M; Kubancak J; Knežević Ž; Liszka M; Majer M; Miljanić S; Ploc O; Schinner K; Stolarczyk L; Trompier F; Wielunski M; Olko P; Harrison RM
Med Phys; 2015 May; 42(5):2572-84. PubMed ID: 25979049
[TBL] [Abstract][Full Text] [Related]
14. Off-axis dose equivalent due to secondary neutrons from uniform scanning proton beams during proton radiotherapy.
Islam MR; Collums TL; Zheng Y; Monson J; Benton ER
Phys Med Biol; 2013 Nov; 58(22):8235-51. PubMed ID: 24201018
[TBL] [Abstract][Full Text] [Related]
15. Analytic estimates of secondary neutron dose in proton therapy.
Anferov V
Phys Med Biol; 2010 Dec; 55(24):7509-22. PubMed ID: 21098918
[TBL] [Abstract][Full Text] [Related]
16. Influence of beam incidence and irradiation parameters on stray neutron doses to healthy organs of pediatric patients treated for an intracranial tumor with passive scattering proton therapy.
Bonfrate A; Farah J; De Marzi L; Delacroix S; Hérault J; Sayah R; Lee C; Bolch WE; Clairand I
Phys Med; 2016 Apr; 32(4):590-9. PubMed ID: 27050170
[TBL] [Abstract][Full Text] [Related]
17. Narrow beam neutron dosimetry.
Ferenci MS
Radiat Prot Dosimetry; 2004; 110(1-4):813-7. PubMed ID: 15353751
[TBL] [Abstract][Full Text] [Related]
18. Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit.
Zheng Y; Fontenot J; Taddei P; Mirkovic D; Newhauser W
Phys Med Biol; 2008 Jan; 53(1):187-201. PubMed ID: 18182696
[TBL] [Abstract][Full Text] [Related]
19. Out-of-field doses for scanning proton radiotherapy of shallowly located paediatric tumours-a comparison of range shifter and 3D printed compensator.
Wochnik A; Stolarczyk L; Ambrožová I; Davídková M; De Saint-Hubert M; Domański S; Domingo C; Knežević Ž; Kopeć R; Kuć M; Majer M; Mojżeszek N; Mares V; Martínez-Rovira I; Caballero-Pacheco MÁ; Pyszka E; Swakoń J; Trinkl S; Tisi M; Harrison R; Olko P
Phys Med Biol; 2021 Jan; 66(3):035012. PubMed ID: 33202399
[TBL] [Abstract][Full Text] [Related]
20. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
Zacharatou Jarlskog C; Paganetti H
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
